MDGL
MADRIGAL PHARMAC
Health Care·Biotechnology·UNITED STATES
$476.89
MCap $11B
as of 2026-06-09
Total
C1w
Fund
C1w
Quant
C1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-10
MIDOS SI
+0.31
Sentiment 24.3%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$476.89
Adaptive Mean
$471.20
+5.69 vs mean
Adaptive σ
9.23
MIDOS BB
$452.73 – $489.67
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
-0.74
ROE
-49.3%
Z -0.60
Rev Gr
126.8%
Z +0.77
EPS Gr
41.3%
Z +0.08
OPM Gr
48.5%
Z -0.02
FCF Yld
-1.9%
Z -0.04
EPS Surp
24.3%
Z +0.15
EPS 3mo Δ
-1066.8%
Z -5.55
Fwd P/E
38.52
Z —
PEGY
0.93
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-10
Q3M
4.62
Q6M
-4.21
Q12M
5.85
MA 30/100
1.038
Bullish (MA30 > MA100)
α (Jensen)
0.4166
β (12M)
0.50
σ (12M)
0.461
Divergence — Fundamentals vs Momentum
Z Percentile
6%
Q Percentile
86%
Divergence
-80.0
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
-24.9
RS Pctl
21%
RS Decile
D3
Persistence
1w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.